DFFN - ディフュ―ジョン・ファ―マシュ―ティカルズ (Diffusion Pharmaceuticals Inc.) ディフュ―ジョン・ファ―マシュ―ティカルズ

 DFFNのチャート


 DFFNの企業情報

symbol DFFN
会社名 Diffusion Pharmaceuticals Inc (ディフュ―ジョン・ファ―マシュ―ティカルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 Diffusion Pharmaceuticals Inc. formerly RestorGenex Corporation is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments including radiation therapy and chemotherapy. The Company''s lead product candidate transcrocetinate sodium also known as trans sodium crocetinate (TSC) is used in various cancer types in which tumor oxygen deprivation (hypoxia) is known to diminish the effectiveness of treatments. The Company''s Diffusion''s technology is targeted at overcoming treatment-resistance in solid cancerous tumors by combining its lead product candidate TSC with standard-of-care radiation and chemotherapy regimens thus effecting a better patient survival outcome without the addition of harmful side effects. Its clinical development plan targets TSC at the radiation and chemotherapy sensitization of hypoxic tumor types with an initial focus on primary brain cancer (glioblastoma or GBM) pancreatic cancer and brain metastases.   ディフュ―ジョン・ファ―マシュ―ティカルズは米国のバイオ医薬品企業。臨床段階で、がん腫瘍の治療に使用するトランスクロセチン酸ナトリウム(TSC)の開発に従事する。がん細胞に対する放射線治療や化学療法の効果を上げるためにTSCを使用する。また、TSCはにきびなど皮膚の疾患の治療にも使用される。本社はバ―ジニア州シャ―ロッツビル。   
本社所在地 1317 Carlton Avenue Suite 200 Charlottesville VA 22902 USA
代表者氏名
代表者役職名
電話番号 +1 434-220-0718
設立年月日 34669
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 11人
url www.diffusionpharma.com
nasdaq_url https://www.nasdaq.com/symbol/dffn
adr_tso
EBITDA EBITDA(百万ドル) -12.11949
終値(lastsale) 0.409
時価総額(marketcap) 20683948.409
時価総額 時価総額(百万ドル) 19.72308
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 6.78838
当期純利益 当期純利益(百万ドル) -11.09095
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Diffusion Pharmaceuticals Inc revenues was not reported. Net loss applicable to common stockholders increased from $7M to $14.3M. Higher net loss reflects FV/Uls Adjust on Derivatives for Hedging decrease from $10.5M (income) to $0K Depreciation increase from $12K to $55K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.54 to -$0.33.

 DFFNのテクニカル分析


 DFFNのニュース

   Diffusion Pharmaceuticals (NASDAQ:DFFN) Announces Quarterly Earnings Results  2021/03/18 15:47:07 Daily Political
Diffusion Pharmaceuticals (NASDAQ:DFFN) issued its quarterly earnings results on Tuesday. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.05) by ($0.01), Yahoo Finance reports. DFFN stock traded down $0.01 during midday trading on Thursday, hitting $1.07. The company’s stock had a trading volume of 5,142,061 […]
   Diffusion Pharma Climbs After Completing Early-Stage TSC Study In COVID-19 Patients - Stocks News Feed  2021/02/16 14:18:23 Stocks News Feed
Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) announces topline data from Phase 1b trial evaluating trans sodium crocetinate (“TSC”) in hospitalized COVID-19 patients with confirmed hypoxemia, the most common cause of tissue hypoxia (deprived of adequate oxygen supply at the tissue level). On Friday, the external safety monitoring committee met to review safety data from the final 1.5 mg/kg dose cohort.… Read More »Diffusion Pharma Climbs After Completing Early-Stage TSC Study In COVID-19 Patients
   Thinking about buying stock in G1 Therapeutics, Strongbridge Biopharma, Soligenix, Pieris Pharmaceuticals, or Diffusion Pharmaceuticals?  2021/02/16 13:31:00 PR Newswire
NEW YORK, Feb. 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GTHX, SBBP, SNGX, PIRS, and DFFN. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Thinking about buying stock in Jaguar Health, Diffusion Pharmaceuticals, FuelCell Energy, eMagin Corp, or Fluent Inc?  2021/01/13 14:31:00 PR Newswire
NEW YORK, Jan. 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JAGX, DFFN, FCEL, EMAN, and FLNT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Insider Buys Diffusion Pharmaceuticals Shares  2020/11/18 11:55:00 Benzinga
Shares of Diffusion Pharmaceuticals Inc (NASDAQ:DFFN) rose by 4.1% from the previous closing price. A Form 4 filing filed with the SEC on …
   Diffusion Pharmaceuticals (NASDAQ:DFFN) Announces Quarterly Earnings Results  2021/03/18 15:47:07 Daily Political
Diffusion Pharmaceuticals (NASDAQ:DFFN) issued its quarterly earnings results on Tuesday. The company reported ($0.06) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.05) by ($0.01), Yahoo Finance reports. DFFN stock traded down $0.01 during midday trading on Thursday, hitting $1.07. The company’s stock had a trading volume of 5,142,061 […]
   Diffusion Pharma Climbs After Completing Early-Stage TSC Study In COVID-19 Patients - Stocks News Feed  2021/02/16 14:18:23 Stocks News Feed
Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) announces topline data from Phase 1b trial evaluating trans sodium crocetinate (“TSC”) in hospitalized COVID-19 patients with confirmed hypoxemia, the most common cause of tissue hypoxia (deprived of adequate oxygen supply at the tissue level). On Friday, the external safety monitoring committee met to review safety data from the final 1.5 mg/kg dose cohort.… Read More »Diffusion Pharma Climbs After Completing Early-Stage TSC Study In COVID-19 Patients
   Thinking about buying stock in G1 Therapeutics, Strongbridge Biopharma, Soligenix, Pieris Pharmaceuticals, or Diffusion Pharmaceuticals?  2021/02/16 13:31:00 PR Newswire
NEW YORK, Feb. 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GTHX, SBBP, SNGX, PIRS, and DFFN. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Thinking about buying stock in Jaguar Health, Diffusion Pharmaceuticals, FuelCell Energy, eMagin Corp, or Fluent Inc?  2021/01/13 14:31:00 PR Newswire
NEW YORK, Jan. 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JAGX, DFFN, FCEL, EMAN, and FLNT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Insider Buys Diffusion Pharmaceuticals Shares  2020/11/18 11:55:00 Benzinga
Shares of Diffusion Pharmaceuticals Inc (NASDAQ:DFFN) rose by 4.1% from the previous closing price. A Form 4 filing filed with the SEC on …
   Diffusion Pharma Climbs After Completing Early-Stage TSC Study In COVID-19 Patients - Stocks News Feed  2021/02/16 14:18:23 Stocks News Feed
Diffusion Pharmaceuticals Inc (NASDAQ: DFFN) announces topline data from Phase 1b trial evaluating trans sodium crocetinate (“TSC”) in hospitalized COVID-19 patients with confirmed hypoxemia, the most common cause of tissue hypoxia (deprived of adequate oxygen supply at the tissue level). On Friday, the external safety monitoring committee met to review safety data from the final 1.5 mg/kg dose cohort.… Read More »Diffusion Pharma Climbs After Completing Early-Stage TSC Study In COVID-19 Patients
   Thinking about buying stock in G1 Therapeutics, Strongbridge Biopharma, Soligenix, Pieris Pharmaceuticals, or Diffusion Pharmaceuticals?  2021/02/16 13:31:00 PR Newswire
NEW YORK, Feb. 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GTHX, SBBP, SNGX, PIRS, and DFFN. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Thinking about buying stock in Jaguar Health, Diffusion Pharmaceuticals, FuelCell Energy, eMagin Corp, or Fluent Inc?  2021/01/13 14:31:00 PR Newswire
NEW YORK, Jan. 13, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JAGX, DFFN, FCEL, EMAN, and FLNT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….
   Insider Buys Diffusion Pharmaceuticals Shares  2020/11/18 11:55:00 Benzinga
Shares of Diffusion Pharmaceuticals Inc (NASDAQ:DFFN) rose by 4.1% from the previous closing price. A Form 4 filing filed with the SEC on …
   Diffusion Pharma’s COVID-19 Treatment Takes a Big Step Forward With the FDA  2020/05/26 14:54:54 24/7 Wall street

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 ディフュ―ジョン・ファ―マシュ―ティカルズ DFFN Diffusion Pharmaceuticals Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)